Yujia Xu

783 total citations
28 papers, 597 citations indexed

About

Yujia Xu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yujia Xu has authored 28 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Hematology and 3 papers in Oncology. Recurrent topics in Yujia Xu's work include Ubiquitin and proteasome pathways (12 papers), Multiple Myeloma Research and Treatments (11 papers) and Protein Degradation and Inhibitors (11 papers). Yujia Xu is often cited by papers focused on Ubiquitin and proteasome pathways (12 papers), Multiple Myeloma Research and Treatments (11 papers) and Protein Degradation and Inhibitors (11 papers). Yujia Xu collaborates with scholars based in China, Canada and United States. Yujia Xu's co-authors include Biyin Cao, Xinliang Mao, Yuanying Zeng, Zubin Zhang, Michael F. Moran, Jiefei Tong, Rong Xiao, Chen-ya Chien, G.T. Montelione and James M. Aramini and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Yujia Xu

27 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujia Xu China 14 421 140 126 112 102 28 597
Katelyn O’Neill United States 11 560 1.3× 137 1.0× 113 0.9× 61 0.5× 162 1.6× 15 813
Sujan Piya United States 15 469 1.1× 136 1.0× 231 1.8× 155 1.4× 77 0.8× 45 695
Yuichiro Amano Japan 14 544 1.3× 74 0.5× 109 0.9× 40 0.4× 78 0.8× 31 820
Hyeong‐jun Han South Korea 14 429 1.0× 173 1.2× 33 0.3× 65 0.6× 87 0.9× 29 623
Juan I. Barrasa Spain 10 404 1.0× 185 1.3× 71 0.6× 26 0.2× 95 0.9× 13 658
Mark Baugh United Kingdom 8 184 0.4× 110 0.8× 63 0.5× 36 0.3× 90 0.9× 9 518
Jiali Si United States 8 554 1.3× 67 0.5× 50 0.4× 197 1.8× 67 0.7× 8 752
Timo Siitonen Finland 16 229 0.5× 131 0.9× 78 0.6× 238 2.1× 74 0.7× 48 572
Qiao‐Yang Sun Singapore 15 446 1.1× 105 0.8× 109 0.9× 41 0.4× 65 0.6× 23 675
Xue-Chun Lu China 12 233 0.6× 182 1.3× 45 0.4× 75 0.7× 209 2.0× 39 560

Countries citing papers authored by Yujia Xu

Since Specialization
Citations

This map shows the geographic impact of Yujia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujia Xu more than expected).

Fields of papers citing papers by Yujia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujia Xu. The network helps show where Yujia Xu may publish in the future.

Co-authorship network of co-authors of Yujia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yujia Xu. A scholar is included among the top collaborators of Yujia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujia Xu. Yujia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Shasha, et al.. (2025). Lactylation-induced ALKBH5 targets RNF123 to worsen retinal Müller cell activation through PKM2-regulated Glycolysis in diabetic retinopathy. Journal of Translational Medicine. 23(1). 1105–1105. 1 indexed citations
2.
3.
4.
Xu, Yujia, Kun Zeng, Ying Ren, et al.. (2023). Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation. Acta Pharmacologica Sinica. 44(9). 1920–1931. 5 indexed citations
5.
Zhang, Zubin, Mei Li, Peng Lin, et al.. (2023). The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination. Journal of Biological Chemistry. 299(5). 104675–104675. 1 indexed citations
6.
Zhuang, Haixia, Ying Ren, Chenyu Mao, et al.. (2022). Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia. Journal of Biological Chemistry. 298(9). 102314–102314. 10 indexed citations
7.
Sun, Tong, Yujia Xu, Biyin Cao, et al.. (2021). Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis. Cell Communication and Signaling. 19(1). 24–24. 21 indexed citations
8.
Lu, Zhaoming, Yalin Zhang, Yujia Xu, et al.. (2021). mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma. Molecular Biology Reports. 49(1). 451–461. 6 indexed citations
9.
Xu, Yujia, Tong Sun, Kun Zeng, et al.. (2020). Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf. Cell Death and Disease. 11(9). 818–818. 11 indexed citations
10.
Sun, Tong, Yujia Xu, Shuoyi Jiang, et al.. (2020). Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis. Acta Pharmacologica Sinica. 42(8). 1338–1346. 50 indexed citations
11.
Lu, Xiaoyong, et al.. (2019). IL‐1β functionally attenuates ABCG2 and PDZK1 expression in HK‐2 cells partially through NF‐ĸB activation. Cell Biology International. 43(3). 279–289. 18 indexed citations
12.
Chen, Xuehan, Yujia Xu, Xiaoge Wang, et al.. (2019). Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis. Acta Pharmacologica Sinica. 40(12). 1568–1577. 33 indexed citations
13.
He, Yuanming, Siyu Wang, Jiefei Tong, et al.. (2019). The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. Journal of Biological Chemistry. 295(7). 2084–2096. 36 indexed citations
14.
Ren, Ying, Xin Xu, Chenyu Mao, et al.. (2019). RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination. Acta Pharmacologica Sinica. 41(3). 394–403. 25 indexed citations
15.
Xu, Yujia, Yanan Hao, Xin Xu, et al.. (2017). A novel STAT3 inhibitor negatively modulates platelet activation and aggregation. Acta Pharmacologica Sinica. 38(5). 651–659. 20 indexed citations
16.
Xu, Yujia, Zubin Zhang, Jie Li, et al.. (2017). The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis. Journal of Hematology & Oncology. 10(1). 132–132. 40 indexed citations
17.
Wang, Siyu, Zubin Zhang, Yanyun Du, et al.. (2017). Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. Cell Death and Disease. 8(9). e3058–e3058. 69 indexed citations
18.
Wang, Siyu, Jie Li, Yanyun Du, et al.. (2017). The Class I PI3K inhibitor S14161 induces autophagy in malignant blood cells by modulating the Beclin 1/Vps34 complex. Journal of Pharmacological Sciences. 134(4). 197–202. 28 indexed citations
19.
Xu, Yujia. (2004). Characterization of macromolecular heterogeneity by equilibrium sedimentation techniques. Biophysical Chemistry. 108(1-3). 141–163. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katelyn O’Neill Breakdown of academic impact, for papers by Sujan Piya Breakdown of academic impact, for papers by Yuichiro Amano Breakdown of academic impact, for papers by Hyeong‐jun Han Breakdown of academic impact, for papers by Juan I. Barrasa Breakdown of academic impact, for papers by Mark Baugh Breakdown of academic impact, for papers by Jiali Si Breakdown of academic impact, for papers by Timo Siitonen Breakdown of academic impact, for papers by Qiao‐Yang Sun Breakdown of academic impact, for papers by Xue-Chun Lu
Rankless by CCL
2026